Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma - 15/08/11
, Hiroshi Saito, PhD, Takahiro Tsuburai, MD, Chiyako Oshikata, MD, Emiko Ono, MD, Hiroyuki Mitomi, MD, Kazuo Akiyama, MD
Reprint requests: Naomi Tsurikisawa, MD, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan 228-8522.Abstract |
Background |
Chronic eosinophilic pneumonia (CEP) with asthma precedes the onset of Churg-Strauss syndrome (CSS) in half of all patients with CSS. It is not known what determines whether patients with CEP after asthma will have CSS.
Objective |
We examined whether activation of regulatory T cells in patients with CEP inhibits CSS development and is otherwise involved in the mechanism of CSS disease.
Methods |
In patients with CSS (n = 38), CEP with asthma (n = 20), and general adult asthma (n = 108), we examined the number of CD4+CD25+ T cells in peripheral blood, as well as levels of expression of the cytokines IL-2, IL-5, IL-10, and TGF-β by CD4+CD25+ T cells, CD4+CD25− T cells, or both.
Results |
At disease onset, patients with CSS, unlike patients with CEP, had significantly fewer CD4+CD25+ T cells than patients with any step of asthma. CD4+CD25+ T cells producing IL-10 were rarely detected in patients with CSS at disease onset or relapse, whereas the numbers of IL-10–producing T cells in patients with CEP were high at disease onset. There were fewer CD4+CD25− T cells producing IL-2 in patients with CSS before treatment than in patients with CEP at disease onset. The proportions of CD4+CD25+ T cells producing IL-10 and CD4+CD25− T cells producing IL-2 in patients with CSS increased at remission.
Conclusions |
Maintenance of the numbers of regulatory T cells in patients with CEP with asthma might inhibit CSS development through the action of cytokines, such as IL-10 and IL-2, produced by CD4+CD25+ or CD4+CD25− T cells. This might be part of a mechanism that influences progression and prognosis in these diseases.
Le texte complet de cet article est disponible en PDF.Key words : Churg–Strauss syndrome, regulatory T cells, chronic eosinophilic pneumonia, CD4+CD25+ T cells, IL-10, TGF-β, IL-2
Abbreviations used : ACR, BALF, CEP, CSS, GINA, MNL, nTreg, PE, Treg, WBC
Plan
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
Vol 122 - N° 3
P. 610-616 - septembre 2008 Retour au numéro
Article précédent
- Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells
- Laurent Mascarell, Vincent Lombardi, Anne Louise, Nathalie Saint-Lu, Henri Chabre, Hélène Moussu, Didier Betbeder, Anne-Marie Balazuc, Laurence Van Overtvelt, Philippe Moingeon
- CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling
- Jennifer Kearley, Douglas S. Robinson, Clare M. Lloyd
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?